서울대학교 중앙도서관

S-Space 소개

My S-Space

로그인이 필요합니다.

Login

S-Space

Browse

Author

Jump to a point in the index

Or type in a year

Sort by
In order
Results/Page
Authors/record

Showing results 1 to 7 of 7

Issue Date	Title / Author(s) / Citation	File	Altmetrics
2012-12	Phase 2 Study of Everolimus Monotherapy in Patients With Nonfunctioning Neuroendocrine Tumors or Pheochromocytomas/Paragangliomas Oh, Do-Youn; Kim, Tae-Won; Park, Young Suk; Shin, Sang Joon; Shin, Seong Hoon; Song, Eun-Kee; Lee, Hyo Jin; Lee, Kewn-Wook; Bang, Yung-Jue Cancer, Vol.118 No.24, pp.6162-6170	DOI
2013-04	Pharmacogenetic analysis of adjuvant FOLFOX for Korean patients with colon cancer Lee, Kyung-Hun; Chang, Hye Jung; Han, Sae-Won; Oh, Do-Youn; Im, Seock-Ah; Bang, Yung-Jue; Kim, Sun Young; Lee, Keun-Wook; Kim, Jee Hyun; Hong, Yong Sang; Kim, Tae Won; Park, Young Suk; Kang, Won Ki; Shin, Sang Joon; Ahn, Joong Bae; Kang, Gyeong Hoon; Jeong, Seung-Yong; Park, Kyu Joo; Park, Jae-Gahb; Kim, Tae-You Cancer Chemotherapy and Pharmacology, Vol.71 No.4, pp.843-851	DOI
2014-02	A Phase II Study of Bevacizumab, Oxaliplatin, and Capecitabine in Patients With Previously Untreated Metastatic Colorectal Cancer A Prospective, Multicenter Trial of the Korean Cancer Study Group Hong, Yong Sang; Lee, Sung Sook; Kim, Kyu-pyo; Lee, Jae-Lyun; Kang, Yoon-Koo; Shin, Sang Joon; Ahn, Joong Bae; Jung, Kyung Hae; Im, Seock-Ah; Kim, Tae-You; Kim, Jee Hyun; Park, Young Suk; Kim, Tae Won American Journal of Clinical Oncology, Vol.37 No.1, pp.19-23	DOI
2014-11	S-1 plus oxaliplatin versus capecitabine plus oxaliplatin for the first-line treatment of patients with metastatic colorectal cancer: updated results from a phase 3 trial Kim, Seung Tae; Hong, Yong Sang; Lim, Ho Yeong; Lee, Jeeyun; Kim, Tae Won; Kim, Kyu-Pyo; Kim, Sun Young; Baek, Ji Yeon; Kim, Jee Hyun; Lee, Keun-Wook; Chung, Ik-Joo; Cho, Sang-Hee; Lee, Kyung Hee; Shin, Sang Joon; Kang, Hye Jin; Shin, Dong Bok; Lee, Jae Won; Jo, Sook Jung; Park, Young Suk BMC Cancer, 14(1):883	view file DOI
2017-06	IL-21-mediated reversal of NK cell exhaustion facilitates anti-tumour immunity in MHC class I-deficient tumours Seo, Hyungseok; Jeon, Insu; Kim, Byung-Seok; Park, Myunghwan; Bae, Eun-Ah; Song, Boyeong; Koh, Choong-Hyun; Shin, Kwang-Soo; Kim, Il-Kyu; Choi, Kiyoung; Oh, Taegwon; Min, Jiyoun; Min, Byung Soh; Han, Yoon Dae; Kang, Suk-Jo; Shin, Sang Joon; Chung, Yeonseok; Kang, Chang-Yuil Nature Communications, Vol.8, p. 15776	DOI
2018-06	IL21 therapy combined with PD-1 and Tim-3 blockade provides enhanced NK cell antitumor activity against MHC class I-deficient tumors Seo, Hyungseok; Kim, Byung-Seok; Bae, Eun-Ah; Min, Byung Soh; Han, Yoon Dae; Shin, Sang Joon; Kang, Chang-Yuil Cancer immunology research, Vol.6 No.6, pp.685-695	DOI
2018-09	Activation of NKT cells in an anti-PD-1-resistant tumor model enhances antitumor immunity by reinvigorating exhausted CD8 T cells Bae, Eun-Ah; Seo, Hyungseok; Kim, Byung-Seok; Choi, Jeongwon; Jeon, Insu; Shin, Kwang-Soo; Koh, Choong-Hyun; Song, Boyeong; Kim, Il-Kyu; Min, Byung Soh; Han, Yoon Dae; Shin, Sang Joon; Kang, Chang-Yuil Cancer Research, Vol.78 No.18, pp.5315-5326	DOI

1